Trial intelligence / Profile preview

Fibrin Sealant to Reduce Post-operative Drainage in Lymph Node Dissection

NCT00324272Phase 4Completed

Sponsor
Oxford University Hospitals
Start
Jan 2003
Primary completion
Dec 2006
Modality
Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
01

Overview

A Phase 4 trial of tisseel in Malignant Melanoma (MM), squamous cell carcinoma (SCC), sponsored by Oxford University Hospitals. Started Jan 2003; status: completed.

02

Drugs

tisseel
03

Conditions

Malignant Melanoma (MM)squamous cell carcinoma (SCC)

Beyond the preview

Go deeper on NCT00324272.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00324272.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call